Literature DB >> 19471624

Liquid ecstasy - a significant drug problem.

Hilke Andresen, Thomas Stimpfl, Nadine Sprys, Tino Schnitgerhans, Alexander Müller.   

Abstract

INTRODUCTION: Gamma-hydroxybutyric acid (GHB, "liquid ecstasy") and its legal pro-drugs gamma-butyrolactone and 1,4-butanediol are gaining in importance as recreational drugs in Germany. The effects of these substances are comparable with those of alcohol or benzodiazepines. Because of the wide availability of GHB physicians are increasingly being confronted with cases of intoxication.
METHODS: This review is based on a selective literature search as well as on the authors' own experience and on information provided by the GIZ-Nord Poisons Centre, Göttingen, Germany.
RESULTS: Consumption of a high dose of GHB or its prodrugs leads to severe intoxication with respiratory depression and coma. Only supportive therapy can be offered; no antidote is available. DISCUSSION: In any patient with impaired consciousness of unknown cause, the possibility of intoxication with GHB must be considered. Chemical detection of GHB in blood or urine is possible only using specific analytical methods and only within a short time frame (<12 h). Because of the short half-life of GHB, intoxications treated in intensive care units rarely show any complications. However, a number of fatalities have occurred. The potential abuse of GHB as a date rape drug must be borne in mind.

Entities:  

Keywords:  designer drugs; diagnosis; gamma-hydroxybutyric acid, drug abuse; liquid ecstasy

Year:  2008        PMID: 19471624      PMCID: PMC2680564          DOI: 10.3238/arztebl.2008.0599

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  17 in total

1.  Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?

Authors:  R Bernasconi; P Mathivet; S Bischoff; C Marescaux
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

2.  Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography--mass spectrometry.

Authors:  F J Couper; B K Logan
Journal:  J Anal Toxicol       Date:  2000 Jan-Feb       Impact factor: 3.367

3.  Recommendations for toxicological investigations of drug-facilitated sexual assaults.

Authors:  M LeBeau; W Andollo; W L Hearn; R Baselt; E Cone; B Finkle; D Fraser; A Jenkins; J Mayer; A Negrusz; A Poklis; H C Walls; L Raymon; M Robertson; J Saady
Journal:  J Forensic Sci       Date:  1999-01       Impact factor: 1.832

Review 4.  Gamma-hydroxybutyrate--a drug of abuse.

Authors:  K R Drasbek; J Christensen; K Jensen
Journal:  Acta Neurol Scand       Date:  2006-09       Impact factor: 3.209

5.  Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage.

Authors:  Laureen J Marinetti; Daniel S Isenschmid; Bradford R Hepler; Sawait Kanluen
Journal:  J Anal Toxicol       Date:  2005 Jan-Feb       Impact factor: 3.367

6.  Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.

Authors:  Rudolf Brenneisen; Mahmoud A Elsohly; Timothy P Murphy; Joseph Passarelli; Stefan Russmann; Salvatore J Salamone; David E Watson
Journal:  J Anal Toxicol       Date:  2004 Nov-Dec       Impact factor: 3.367

7.  A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography-mass spectrometry.

Authors:  C E Crookes; M C Faulds; A R W Forrest; J H Galloway
Journal:  J Anal Toxicol       Date:  2004 Nov-Dec       Impact factor: 3.367

8.  Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.

Authors:  P Palatini; L Tedeschi; G Frison; R Padrini; R Zordan; R Orlando; L Gallimberti; G L Gessa; S D Ferrara
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Distribution of GHB in tissues and fluids following a fatal overdose.

Authors:  Susan Mazarr-Proo; Sarah Kerrigan
Journal:  J Anal Toxicol       Date:  2005 Jul-Aug       Impact factor: 3.367

10.  From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.

Authors:  David E Fuller; Carl S Hornfeldt
Journal:  Pharmacotherapy       Date:  2003-09       Impact factor: 4.705

View more
  2 in total

1.  Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study.

Authors:  Ann-Sofie M E Ingels; Katrien B Hertegonne; Willy E Lambert; Christophe P Stove
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

2.  Knock-out drugs: their prevalence, modes of action, and means of detection.

Authors:  Burkhard Madea; Frank Musshoff
Journal:  Dtsch Arztebl Int       Date:  2009-05-15       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.